Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...
Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...
(MENAFN- EIN Presswire) EINPresswire/ -- Ainnocence and Phase Advance Announce Industry-First AI Collaboration to Transform Drug Development Timelines and Reduce Clinical Trial Risk Ainnocence, a next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results